Sleepy medical staff run increased risks of accidents driving home after a night shift

 

Paris, France (June 8, 2012) – The drowsiness experienced by medical staff who have been on night duty can make their driving dangerous, French researchers have found. The first study to use simulated driving tests on medical staff returning home after a night shift showed that, under the monotonous driving conditions similar to those experienced on autoroutes (motorways or highways), it was more difficult for them to hold a straight line while driving than it was when they had not been working overnight. They also had greater difficulty in controlling their speed when driving in monotonous conditions.

 

Dr. Ségolène Arzalier-Daret, from the Department of Anaesthesiology and Intensive Care, Caen Teaching Hospital, Caen, France, will tell the annual conference of the European Society of Anaesthesiology tomorrow (Sunday) that she hopes her research will raise awareness among medical staff about the dangers of driving when sleep deprived. "Sleepiness at the wheel is a public health problem in France, the first cause of death on the autoroute network in 2009, and responsible for many crashes in towns the same year. There have been a number of campaigns to promote knowledge of this problem, but these statistics show us that there is a long way to go."

 

Dr. Arzalier-Daret and her team looked at the driving skills of 30 anaesthesia trainees in a sleep-deprived condition (SDC) and after a night of normal sleep. All tests were carried out in a simulated driving laboratory at 8am. Participants drove for 15 minutes in urban conditions, followed by the monotonous conditions of 60 minutes on the autoroute. The researchers then analysed the participants‘ reaction times, average speed and the numbers of crashes in urban conditions, and the deviation of lateral position (failure to keep to a straight line) and variations in speed in autoroute conditions.

 

"We found that there were differences between those who had had a normal sleep and those who were sleep-deprived because of working overnight," says Dr. Arzalier-Daret. "In urban conditions, sleep-deprived drivers drove at an average of 2km per hour slower than those who had had a normal night’s sleep, perhaps because they were aware that their driving skills might have been affected. Lateral deviation and speed variations were more significant in sleep-deprived drivers under monotonous conditions than in those who had slept normally. We know from official statistics that road accidents peak between 8 and 9 am*, so it is particularly worrying that the trainees normally finish their shift around this time."

 

Apart from the acute sleep deprivation suffered by the participants in the study, medical staff who are regularly on call at night often suffer from chronic sleep deprivation, say the researchers. They suggest that hospital staff should have the opportunity to rest in the hospital before driving home, particularly if they live more than 20 minutes away. "The differences in driving skills between those who were sleep deprived and those who were not appeared after 20 minutes (lateral deviation) and 30 minutes (speed)," Dr. Arzalier-Daret will say, "and we believe that staff who live further than 20 minutes‘ drive from their place of work should have the opportunity to rest before taking the wheel after a shift of night duty."

 

Drinking a coffee between half an hour to one hour before driving also helps to avoid drowsiness, the researchers say, but safest of all would be for employers to provide taxis home, as happens at some hospitals in the United States. Reducing the number of hours worked consecutively, as has happened in Canada where night duty hours have been cut from 24 to 16 would also help, but this could lead to staffing problems at a time when there are already shortages.

 

"Car manufacturers and road authorities can also play their part, by making electronic systems to alert the driver to sideways movement of their vehicle more widely available, changing road markings and installing bands that give off audible warnings when a driver accidentally enters the hard shoulder," says Dr. Arzalier-Daret.

 

Although the study was simulated, the researchers believe that the results are likely to be replicated in real life. The study subjects also completed a questionnaire in which 13% said that they had gone to sleep at the wheel after night duty, 11% had had an accident when leaving work after their shift, and 6% attributed that accident to going to sleep. Going to sleep at the wheel is likely to be under-estimated because, if the sleep episode is very brief, drivers are not always conscious of it.

 

"Personally, I don’t like driving home after work after a night shift, though I only live five minutes away," says Dr. Arzalier-Daret. "Even though our study didn’t show any definitive proof that driving conduct was altered in town, as opposed to on the autoroute, I know that I have driven on autopilot and haven’t remembered anything about the journey when I arrived home. And epidemiological studies show that fatal accidents due to somnolence mainly happen in town and on short journeys.

 

"I hope that our work will help to raise awareness of the dangers of driving when tired, and that employers of those who have to work night shifts will take measures to protect their staff from these dangers," she will conclude.

 

 

* Observatoire national interministériel de sécurité routière. La sécurité routière en France, bilan de l´année 2009. La documentation Française 2010. Synthèse générale:8-34.

 

Abstract no: ESAAP1-1, Sunday, 08.30 hrs, Salle Passy

 

Euroanaesthesia 2012, the European Anaesthesiology Congress, is taking place from June 9-12 at the Palais des Congrès, Paris, France. A total of 807 abstracts will be presented at the Congress, and about 6000 delegates from over 90 countries around the world will be attending.

 

 


ESA (European Society of Anaesthesiology), 08.06.2012 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…